These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2134017)

  • 1. Oral vaccination using recombinant bacteria.
    Schödel F
    Semin Immunol; 1990 Sep; 2(5):341-9. PubMed ID: 2134017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of live attenuated Salmonella for oral vaccination.
    Chatfield S; Roberts M; Li J; Starns A; Dougan G
    Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella: immune responses and vaccines.
    Mastroeni P; Chabalgoity JA; Dunstan SJ; Maskell DJ; Dougan G
    Vet J; 2001 Mar; 161(2):132-64. PubMed ID: 11243685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variation of antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines.
    Yan ZX; Meyer TF
    Behring Inst Mitt; 1994 Dec; (95):49-56. PubMed ID: 7755509
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella.
    Rüssmann H
    Int J Med Microbiol; 2003 Apr; 293(1):107-12. PubMed ID: 12755371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed population approach for vaccination with live recombinant Salmonella strains.
    Yan ZX; Meyer TF
    J Biotechnol; 1996 Jan; 44(1-3):197-201. PubMed ID: 8717404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonella-based plague vaccines for bioterrorism.
    Calhoun LN; Kwon YM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):92-7. PubMed ID: 16604240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for oral vaccination using recombinant bacteria expressing viral epitopes.
    Schödel F
    Adv Virus Res; 1992; 41():409-46. PubMed ID: 1374212
    [No Abstract]   [Full Text] [Related]  

  • 13. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK
    Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-displayed viral antigens on Salmonella carrier vaccine.
    Lee JS; Shin KS; Pan JG; Kim CJ
    Nat Biotechnol; 2000 Jun; 18(6):645-8. PubMed ID: 10835603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vector-primed mice display hypo-responsiveness to foreign antigen presented by recombinant Salmonella regardless of the route of delivery.
    Attridge SR; Vindurampulle CJ
    Microb Pathog; 2005; 39(1-2):1-7. PubMed ID: 16002258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    LeCureux JS; Dean GA
    mSphere; 2018; 3(3):. PubMed ID: 29769376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine.
    Pascual DW; Powell RJ; Lewis GK; Hone DM
    Behring Inst Mitt; 1997 Feb; (98):143-52. PubMed ID: 9382735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recombinant antigen vaccines for the control of theileriosis.
    Musoke AJ; Nene V
    Parassitologia; 1990 Apr; 32(1):73-85. PubMed ID: 2149448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective delivery of antigens by recombinant bacteria.
    Curtiss R; Kelly SM; Gulig PA; Nakayama K
    Curr Top Microbiol Immunol; 1989; 146():35-49. PubMed ID: 2659274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.